Parallel Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
127,424
+117,424
| +1,174% | +$116K | ﹤0.01% | 1243 |
|
|
2025
Q1 | $14.4K | Hold |
10,000
| – | – | ﹤0.01% | 2277 |
|
|
2024
Q4 | $22K | Sell |
10,000
-234,000
| -96% | -$515K | ﹤0.01% | 2080 |
|
|
2024
Q3 | $403K | Buy |
244,000
+5,000
| +2% | +$8.25K | 0.01% | 640 |
|
|
2024
Q2 | $531K | Hold |
239,000
| – | – | 0.01% | 519 |
|
|
2024
Q1 | $641K | Sell |
239,000
-239,000
| -50% | -$641K | 0.02% | 456 |
|
|
2023
Q4 | $1.43M | Hold |
478,000
| – | – | 0.04% | 268 |
|
|
2023
Q3 | $468K | Buy |
+478,000
| New | +$468K | 0.02% | 474 |
|
|
2023
Q2 | – | Sell |
-169
| Closed | -$269 | – | 3404 |
|
|
2023
Q1 | $269 | Buy |
+169
| New | +$269 | ﹤0.01% | 3245 |
|
|
2022
Q4 | – | Sell |
-53
| Closed | – | – | 3399 |
|
|
2022
Q3 | $0 | Buy |
53
+18
| +51% | – | ﹤0.01% | 3218 |
|
|
2022
Q2 | $0 | Buy |
+35
| New | – | ﹤0.01% | 3064 |
|
|
2022
Q1 | – | Sell |
-1,526
| Closed | -$8K | – | 3046 |
|
|
2021
Q4 | $8K | Buy |
1,526
+1,400
| +1,111% | +$7.34K | ﹤0.01% | 2186 |
|
|
2021
Q3 | $2K | Buy |
126
+124
| +6,200% | +$1.97K | ﹤0.01% | 2653 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2943 |
|
|
2021
Q1 | $0 | Sell |
2
-3
| -60% | – | ﹤0.01% | 2807 |
|
|
2020
Q4 | $0 | Sell |
5
-5
| -50% | – | ﹤0.01% | 2582 |
|
|
2020
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2567 |
|
|
2020
Q2 | – | Sell |
-17,710
| Closed | -$558K | – | 2507 |
|
|
2020
Q1 | $558K | Hold |
17,710
| – | – | 0.05% | 225 |
|
|
2019
Q4 | $1.06M | Buy |
17,710
+10,000
| +130% | +$596K | 0.08% | 176 |
|
|
2019
Q3 | $283K | Buy |
+7,710
| New | +$283K | 0.02% | 381 |
|
|
2019
Q2 | – | Sell |
-2,000
| Closed | -$80K | – | 2332 |
|
|
2019
Q1 | $80K | Buy |
+2,000
| New | +$80K | 0.01% | 681 |
|